Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

43.69
Delayed Data
As of 3:59pm ET
 +0.98 / +2.29%
Today’s Change
37.59
Today|||52-Week Range
74.66
-19.20%
Year-to-Date

Today’s Trading

Previous close42.71
Today’s open43.37
Day’s range41.85 - 44.56
Volume11,911,918
Average volume (3 months)5,733,460
Market cap$21.7B
Dividend yield--
Data as of 3:59pm ET, 05/03/2016

Growth & Valuation

Earnings growth (last year)-27.35%
Earnings growth (this year)+14.17%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+21.91%
P/E ratio18.8
Price/Sales2.84
Price/Book2.15

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...-0.84-1.01%
ZTSZoetis Inc+0.12+0.25%
BMRNBiomarin Pharmaceuti...-1.81-2.08%
INCYIncyte Corp-2.27-3.05%
Data as of 4:02pm ET, 05/03/2016

Financials

Last reporting dateMay 3, 2016
EPS forecast (this quarter)$0.76
Annual revenue (last year)$9.5B
Annual profit (last year)$847.6M
Net profit margin8.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts

Partner Offers

Search for Jobs